Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Docetaxel +doxorubicin+ cyclophosphamide|DRUG: Docetaxel +Cisplatin
Sponsor: Henan Cancer Hospital